Related Experiment Video
Updated: Aug 17, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Phosphate enema poisoning in children
J C Craig1, E M Hodson, H C Martin
1Royal Alexandra Hospital for Children, Camperdown, NSW.
Insights
Phosphate enemas can cause severe hypocalcaemia and dehydration in young children. These enemas should be avoided in children under two and used cautiously in those aged two to five, especially with existing bowel or kidney issues.
Area of Science:
- Pediatric Gastroenterology
- Clinical Toxicology
- Pediatric Nephrology
Background:
- Phosphate enemas are commonly used for fecal retention in children.
- Underlying conditions like anorectal malformation and renal hypodysplasia may increase risk.
- Toxicity data in young children is limited.
Observation:
- A 23-month-old child developed hypocalcaemic tetany, hyperphosphataemia, hypokalaemia, and dehydration after two phosphate enemas.
- The child had a history of repaired anorectal malformation and unilateral renal hypodysplasia.
- Symptoms manifested 10 hours post-administration.
Findings:
- Phosphate enema administration led to significant electrolyte disturbances and dehydration.
- Management included rehydration, electrolyte correction, calcium supplementation, and phosphate binders.
- The child recovered fully without neurological sequelae.
Implications:
- Phosphate enemas are associated with substantial morbidity in children under five.
- Avoidance is recommended for children under two years of age.
- Extreme caution is advised for children aged two to five, particularly those with renal or bowel dysfunction.
Objective:
To report a case of hypocalcaemic tetany occurring in a child secondary to two phosphate enemas administered for faecal retention, and review the literature of phosphate enema toxicity in children.
Clinical Features:
A 23-month-old child with a repaired anorectal malformation and associated unilateral renal hypodysplasia presented with hypocalcaemic tetany (minimum serum calcium level, 1.11 mmol/L), hyperphosphataemia (maximum serum phosphate level, 6.06 mmol/L), hypokalaemia (minimum serum potassium level, 1.9 mmol/L) and dehydration 10 hours after the administration of two phosphate enemas for acute on chronic faecal retention. MANAGEMENT AND OUTCOME: Management consisted of parenteral rehydration, potassium supplementation, calcium gluconate, an enterally administered phosphate binder and saline bowel washouts to evacuate the remaining enema. She was discharged on day eight, with normal biochemical parameters and no neurological sequelae.
Conclusion:
The use of phosphate enemas in children under five years of age is associated with significant morbidity due to hyperphosphataemia, hypocalcaemia, hypokalaemia and dehydration. They should not be used in children under two years of age, and should be used only with extreme caution in children aged two to five years, especially in those with underlying bowel or renal dysfunction.
Related Concept Videos
Introduction to Electrolytes
Role of Sodium
One...
Prevention of Further Absorption of Poison
Enhanced Elimination of Poison
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical Poisoning: Treatment Strategies

